Science Explorer Back to mapMap
Discussion
Researcher · University of California San Diego · United States

Douglas D. Richman

Douglas D. Richman publishes mostly in Infectious Diseases, Virology and Epidemiology, on topics such as HIV Research and Treatment, HIV/AIDS drug development and treatment and HIV/AIDS Research and Interventions.

ORCID 0000-0003-0962-9254 OpenAlex
World rank
#58,730
of 7,710,434 ranked researchers
Rank in United States
#22,632
of 1,627,098
Works
644
Citations
79k
Citations per work
122.0
h-index
134
i10-index 465Top 0.1% in Infectious Diseases
Douglas D. Richman

What does Douglas D. Richman research?

Douglas D. Richman's work is mostly in Medicine (50%), Immunology and Microbiology (32%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 320 works · 49.7% of their workMedicine: 320 works · 49.7% of their workInfectious Diseases: 220 works · 34.1% of their workEpidemiology: 82 works · 12.8% of their workEmergency Medicine: 18 works · 2.8% of their workLife Sciences: 231 works · 35.8% of their workImmunology and Microbiology: 207 works · 32.2% of their workVirology: 160 works · 24.8% of their workImmunology: 48 works · 7.4% of their workBiochemistry, Genetics and Molecular Biology: 23 works · 3.6% of their workMolecular Biology: 23 works · 3.6% of their workEverything else: 93 works · 14.5% of their workTHEIR WORKDouglas D.Richman644works
Life Sciences36%Health Sciences50%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine32049.7%
    1. Immunology and Microbiology20732.2%
    2. Biochemistry, Genetics and Molecular Biology233.6%
  3. Everything else9314.5%
  1. 1Infectious Diseases34% of their works
  2. 2Virology25% of their works
  3. 3Epidemiology13% of their works
  4. 4Immunology7% of their works
  5. 5Molecular Biology4% of their works
  6. 6Emergency Medicine3% of their works

Research topics

Which keywords describe Douglas D. Richman's research?

The keywords of their largest research topics: Antiretroviral Therapy, HIV, Vaccine, AIDS, Antibodies, HIV Infection, Drug Resistance and Integrase Inhibitors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Antiretroviral Therapy1,1265 topics
  2. HIV4872 topics
  3. Vaccine4872 topics
  4. AIDS4521 topic
  5. Antibodies4521 topic
  6. HIV Infection3822 topics
  7. Drug Resistance3311 topic
  8. Integrase Inhibitors3311 topic
  9. HIV Transmission2571 topic
  10. Preexposure Prophylaxis2571 topic
  11. NK Cell Recognition711 topic
  12. Natural Killer Cells711 topic
  13. Cytomegalovirus701 topic
  14. Epidemiology702 topics
  15. Infection701 topic
  16. Cardiovascular Disease511 topic
  17. Inflammation511 topic
  18. Herpes Zoster351 topic
  19. Herpesviruses351 topic
  20. Pneumocystis351 topic
  21. Pneumonia351 topic

Where does Douglas D. Richman work?

Douglas D. Richman's main affiliation in the publication record is University of California San Diego, United States.

How many publications and citations does Douglas D. Richman have?

OpenAlex counts 644 works and 78,563 citations for Douglas D. Richman, an h-index of 134, ranking #58,730 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Douglas D. Richman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.